Global Prostate Cancer Diagnostics Solution Market Research Report 2023
The prostate is a walnut-sized gland located behind the base of a man’s penis, in front of the rectum, and below the bladder. Cancer begins when healthy cells in the prostate change and grow out of control, forming a tumor. A tumor can be cancerous or benign. A cancerous tumor is malignant, meaning it can grow and spread to other parts of the body. A benign tumor means the tumor can grow but will not spread.Prostate cancer diagnostics solution refers to using PSA, rectal exam, biopsy and others to diagnostic whether patients with breast cancer.
According to QYResearch’s new survey, global Prostate Cancer Diagnostics Solution market is projected to reach US$ 22860 million in 2029, increasing from US$ 13430 million in 2022, with the CAGR of 7.8% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Prostate Cancer Diagnostics Solution market research.
Key companies engaged in the Prostate Cancer Diagnostics Solution industry include OPKO, Genomic Health, Abbott, Beckman Coulter, Siemens Healthcare, bioMeriux, Roche, MDx Health and DiaSorin, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Prostate Cancer Diagnostics Solution were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Prostate Cancer Diagnostics Solution market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Prostate Cancer Diagnostics Solution market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
According to QYResearch’s new survey, global Prostate Cancer Diagnostics Solution market is projected to reach US$ 22860 million in 2029, increasing from US$ 13430 million in 2022, with the CAGR of 7.8% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Prostate Cancer Diagnostics Solution market research.
Key companies engaged in the Prostate Cancer Diagnostics Solution industry include OPKO, Genomic Health, Abbott, Beckman Coulter, Siemens Healthcare, bioMeriux, Roche, MDx Health and DiaSorin, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Prostate Cancer Diagnostics Solution were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Prostate Cancer Diagnostics Solution market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Prostate Cancer Diagnostics Solution market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
- OPKO
- Genomic Health
- Abbott
- Beckman Coulter
- Siemens Healthcare
- bioMeriux
- Roche
- MDx Health
- DiaSorin
- Myriad Genetics
- Ambry Genetics
- Tumor Biomarker Tests
- Imaging
- Biopsy
- Other
- Age Below 55
- Age 55-75
- Age Above 75
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prostate Cancer Diagnostics Solution Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Tumor Biomarker Tests
1.2.3 Imaging
1.2.4 Biopsy
1.2.5 Other
1.3 Market by Application
1.3.1 Global Prostate Cancer Diagnostics Solution Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Age Below
1.3.3 Age 55-75
1.3.4 Age Above
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Prostate Cancer Diagnostics Solution Market Perspective (2018-2029)
2.2 Prostate Cancer Diagnostics Solution Growth Trends by Region
2.2.1 Global Prostate Cancer Diagnostics Solution Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Prostate Cancer Diagnostics Solution Historic Market Size by Region (2018-2023)
2.2.3 Prostate Cancer Diagnostics Solution Forecasted Market Size by Region (2024-2029)
2.3 Prostate Cancer Diagnostics Solution Market Dynamics
2.3.1 Prostate Cancer Diagnostics Solution Industry Trends
2.3.2 Prostate Cancer Diagnostics Solution Market Drivers
2.3.3 Prostate Cancer Diagnostics Solution Market Challenges
2.3.4 Prostate Cancer Diagnostics Solution Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Prostate Cancer Diagnostics Solution Players by Revenue
3.1.1 Global Top Prostate Cancer Diagnostics Solution Players by Revenue (2018-2023)
3.1.2 Global Prostate Cancer Diagnostics Solution Revenue Market Share by Players (2018-2023)
3.2 Global Prostate Cancer Diagnostics Solution Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Prostate Cancer Diagnostics Solution Revenue
3.4 Global Prostate Cancer Diagnostics Solution Market Concentration Ratio
3.4.1 Global Prostate Cancer Diagnostics Solution Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prostate Cancer Diagnostics Solution Revenue in 2022
3.5 Prostate Cancer Diagnostics Solution Key Players Head office and Area Served
3.6 Key Players Prostate Cancer Diagnostics Solution Product Solution and Service
3.7 Date of Enter into Prostate Cancer Diagnostics Solution Market
3.8 Mergers & Acquisitions, Expansion Plans
4 PROSTATE CANCER DIAGNOSTICS SOLUTION BREAKDOWN DATA BY TYPE
4.1 Global Prostate Cancer Diagnostics Solution Historic Market Size by Type (2018-2023)
4.2 Global Prostate Cancer Diagnostics Solution Forecasted Market Size by Type (2024-2029)
5 PROSTATE CANCER DIAGNOSTICS SOLUTION BREAKDOWN DATA BY APPLICATION
5.1 Global Prostate Cancer Diagnostics Solution Historic Market Size by Application (2018-2023)
5.2 Global Prostate Cancer Diagnostics Solution Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Prostate Cancer Diagnostics Solution Market Size (2018-2029)
6.2 North America Prostate Cancer Diagnostics Solution Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Prostate Cancer Diagnostics Solution Market Size by Country (2018-2023)
6.4 North America Prostate Cancer Diagnostics Solution Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Prostate Cancer Diagnostics Solution Market Size (2018-2029)
7.2 Europe Prostate Cancer Diagnostics Solution Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Prostate Cancer Diagnostics Solution Market Size by Country (2018-2023)
7.4 Europe Prostate Cancer Diagnostics Solution Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Prostate Cancer Diagnostics Solution Market Size (2018-2029)
8.2 Asia-Pacific Prostate Cancer Diagnostics Solution Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Prostate Cancer Diagnostics Solution Market Size by Region (2018-2023)
8.4 Asia-Pacific Prostate Cancer Diagnostics Solution Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Prostate Cancer Diagnostics Solution Market Size (2018-2029)
9.2 Latin America Prostate Cancer Diagnostics Solution Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Prostate Cancer Diagnostics Solution Market Size by Country (2018-2023)
9.4 Latin America Prostate Cancer Diagnostics Solution Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Prostate Cancer Diagnostics Solution Market Size (2018-2029)
10.2 Middle East & Africa Prostate Cancer Diagnostics Solution Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Prostate Cancer Diagnostics Solution Market Size by Country (2018-2023)
10.4 Middle East & Africa Prostate Cancer Diagnostics Solution Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 OPKO
11.1.1 OPKO Company Detail
11.1.2 OPKO Business Overview
11.1.3 OPKO Prostate Cancer Diagnostics Solution Introduction
11.1.4 OPKO Revenue in Prostate Cancer Diagnostics Solution Business (2018-2023)
11.1.5 OPKO Recent Development
11.2 Genomic Health
11.2.1 Genomic Health Company Detail
11.2.2 Genomic Health Business Overview
11.2.3 Genomic Health Prostate Cancer Diagnostics Solution Introduction
11.2.4 Genomic Health Revenue in Prostate Cancer Diagnostics Solution Business (2018-2023)
11.2.5 Genomic Health Recent Development
11.3 Abbott
11.3.1 Abbott Company Detail
11.3.2 Abbott Business Overview
11.3.3 Abbott Prostate Cancer Diagnostics Solution Introduction
11.3.4 Abbott Revenue in Prostate Cancer Diagnostics Solution Business (2018-2023)
11.3.5 Abbott Recent Development
11.4 Beckman Coulter
11.4.1 Beckman Coulter Company Detail
11.4.2 Beckman Coulter Business Overview
11.4.3 Beckman Coulter Prostate Cancer Diagnostics Solution Introduction
11.4.4 Beckman Coulter Revenue in Prostate Cancer Diagnostics Solution Business (2018-2023)
11.4.5 Beckman Coulter Recent Development
11.5 Siemens Healthcare
11.5.1 Siemens Healthcare Company Detail
11.5.2 Siemens Healthcare Business Overview
11.5.3 Siemens Healthcare Prostate Cancer Diagnostics Solution Introduction
11.5.4 Siemens Healthcare Revenue in Prostate Cancer Diagnostics Solution Business (2018-2023)
11.5.5 Siemens Healthcare Recent Development
11.6 bioMeriux
11.6.1 bioMeriux Company Detail
11.6.2 bioMeriux Business Overview
11.6.3 bioMeriux Prostate Cancer Diagnostics Solution Introduction
11.6.4 bioMeriux Revenue in Prostate Cancer Diagnostics Solution Business (2018-2023)
11.6.5 bioMeriux Recent Development
11.7 Roche
11.7.1 Roche Company Detail
11.7.2 Roche Business Overview
11.7.3 Roche Prostate Cancer Diagnostics Solution Introduction
11.7.4 Roche Revenue in Prostate Cancer Diagnostics Solution Business (2018-2023)
11.7.5 Roche Recent Development
11.8 MDx Health
11.8.1 MDx Health Company Detail
11.8.2 MDx Health Business Overview
11.8.3 MDx Health Prostate Cancer Diagnostics Solution Introduction
11.8.4 MDx Health Revenue in Prostate Cancer Diagnostics Solution Business (2018-2023)
11.8.5 MDx Health Recent Development
11.9 DiaSorin
11.9.1 DiaSorin Company Detail
11.9.2 DiaSorin Business Overview
11.9.3 DiaSorin Prostate Cancer Diagnostics Solution Introduction
11.9.4 DiaSorin Revenue in Prostate Cancer Diagnostics Solution Business (2018-2023)
11.9.5 DiaSorin Recent Development
11.10 Myriad Genetics
11.10.1 Myriad Genetics Company Detail
11.10.2 Myriad Genetics Business Overview
11.10.3 Myriad Genetics Prostate Cancer Diagnostics Solution Introduction
11.10.4 Myriad Genetics Revenue in Prostate Cancer Diagnostics Solution Business (2018-2023)
11.10.5 Myriad Genetics Recent Development
11.11 Ambry Genetics
11.11.1 Ambry Genetics Company Detail
11.11.2 Ambry Genetics Business Overview
11.11.3 Ambry Genetics Prostate Cancer Diagnostics Solution Introduction
11.11.4 Ambry Genetics Revenue in Prostate Cancer Diagnostics Solution Business (2018-2023)
11.11.5 Ambry Genetics Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prostate Cancer Diagnostics Solution Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Tumor Biomarker Tests
1.2.3 Imaging
1.2.4 Biopsy
1.2.5 Other
1.3 Market by Application
1.3.1 Global Prostate Cancer Diagnostics Solution Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Age Below
1.3.3 Age 55-75
1.3.4 Age Above
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Prostate Cancer Diagnostics Solution Market Perspective (2018-2029)
2.2 Prostate Cancer Diagnostics Solution Growth Trends by Region
2.2.1 Global Prostate Cancer Diagnostics Solution Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Prostate Cancer Diagnostics Solution Historic Market Size by Region (2018-2023)
2.2.3 Prostate Cancer Diagnostics Solution Forecasted Market Size by Region (2024-2029)
2.3 Prostate Cancer Diagnostics Solution Market Dynamics
2.3.1 Prostate Cancer Diagnostics Solution Industry Trends
2.3.2 Prostate Cancer Diagnostics Solution Market Drivers
2.3.3 Prostate Cancer Diagnostics Solution Market Challenges
2.3.4 Prostate Cancer Diagnostics Solution Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Prostate Cancer Diagnostics Solution Players by Revenue
3.1.1 Global Top Prostate Cancer Diagnostics Solution Players by Revenue (2018-2023)
3.1.2 Global Prostate Cancer Diagnostics Solution Revenue Market Share by Players (2018-2023)
3.2 Global Prostate Cancer Diagnostics Solution Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Prostate Cancer Diagnostics Solution Revenue
3.4 Global Prostate Cancer Diagnostics Solution Market Concentration Ratio
3.4.1 Global Prostate Cancer Diagnostics Solution Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prostate Cancer Diagnostics Solution Revenue in 2022
3.5 Prostate Cancer Diagnostics Solution Key Players Head office and Area Served
3.6 Key Players Prostate Cancer Diagnostics Solution Product Solution and Service
3.7 Date of Enter into Prostate Cancer Diagnostics Solution Market
3.8 Mergers & Acquisitions, Expansion Plans
4 PROSTATE CANCER DIAGNOSTICS SOLUTION BREAKDOWN DATA BY TYPE
4.1 Global Prostate Cancer Diagnostics Solution Historic Market Size by Type (2018-2023)
4.2 Global Prostate Cancer Diagnostics Solution Forecasted Market Size by Type (2024-2029)
5 PROSTATE CANCER DIAGNOSTICS SOLUTION BREAKDOWN DATA BY APPLICATION
5.1 Global Prostate Cancer Diagnostics Solution Historic Market Size by Application (2018-2023)
5.2 Global Prostate Cancer Diagnostics Solution Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Prostate Cancer Diagnostics Solution Market Size (2018-2029)
6.2 North America Prostate Cancer Diagnostics Solution Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Prostate Cancer Diagnostics Solution Market Size by Country (2018-2023)
6.4 North America Prostate Cancer Diagnostics Solution Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Prostate Cancer Diagnostics Solution Market Size (2018-2029)
7.2 Europe Prostate Cancer Diagnostics Solution Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Prostate Cancer Diagnostics Solution Market Size by Country (2018-2023)
7.4 Europe Prostate Cancer Diagnostics Solution Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Prostate Cancer Diagnostics Solution Market Size (2018-2029)
8.2 Asia-Pacific Prostate Cancer Diagnostics Solution Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Prostate Cancer Diagnostics Solution Market Size by Region (2018-2023)
8.4 Asia-Pacific Prostate Cancer Diagnostics Solution Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Prostate Cancer Diagnostics Solution Market Size (2018-2029)
9.2 Latin America Prostate Cancer Diagnostics Solution Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Prostate Cancer Diagnostics Solution Market Size by Country (2018-2023)
9.4 Latin America Prostate Cancer Diagnostics Solution Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Prostate Cancer Diagnostics Solution Market Size (2018-2029)
10.2 Middle East & Africa Prostate Cancer Diagnostics Solution Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Prostate Cancer Diagnostics Solution Market Size by Country (2018-2023)
10.4 Middle East & Africa Prostate Cancer Diagnostics Solution Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 OPKO
11.1.1 OPKO Company Detail
11.1.2 OPKO Business Overview
11.1.3 OPKO Prostate Cancer Diagnostics Solution Introduction
11.1.4 OPKO Revenue in Prostate Cancer Diagnostics Solution Business (2018-2023)
11.1.5 OPKO Recent Development
11.2 Genomic Health
11.2.1 Genomic Health Company Detail
11.2.2 Genomic Health Business Overview
11.2.3 Genomic Health Prostate Cancer Diagnostics Solution Introduction
11.2.4 Genomic Health Revenue in Prostate Cancer Diagnostics Solution Business (2018-2023)
11.2.5 Genomic Health Recent Development
11.3 Abbott
11.3.1 Abbott Company Detail
11.3.2 Abbott Business Overview
11.3.3 Abbott Prostate Cancer Diagnostics Solution Introduction
11.3.4 Abbott Revenue in Prostate Cancer Diagnostics Solution Business (2018-2023)
11.3.5 Abbott Recent Development
11.4 Beckman Coulter
11.4.1 Beckman Coulter Company Detail
11.4.2 Beckman Coulter Business Overview
11.4.3 Beckman Coulter Prostate Cancer Diagnostics Solution Introduction
11.4.4 Beckman Coulter Revenue in Prostate Cancer Diagnostics Solution Business (2018-2023)
11.4.5 Beckman Coulter Recent Development
11.5 Siemens Healthcare
11.5.1 Siemens Healthcare Company Detail
11.5.2 Siemens Healthcare Business Overview
11.5.3 Siemens Healthcare Prostate Cancer Diagnostics Solution Introduction
11.5.4 Siemens Healthcare Revenue in Prostate Cancer Diagnostics Solution Business (2018-2023)
11.5.5 Siemens Healthcare Recent Development
11.6 bioMeriux
11.6.1 bioMeriux Company Detail
11.6.2 bioMeriux Business Overview
11.6.3 bioMeriux Prostate Cancer Diagnostics Solution Introduction
11.6.4 bioMeriux Revenue in Prostate Cancer Diagnostics Solution Business (2018-2023)
11.6.5 bioMeriux Recent Development
11.7 Roche
11.7.1 Roche Company Detail
11.7.2 Roche Business Overview
11.7.3 Roche Prostate Cancer Diagnostics Solution Introduction
11.7.4 Roche Revenue in Prostate Cancer Diagnostics Solution Business (2018-2023)
11.7.5 Roche Recent Development
11.8 MDx Health
11.8.1 MDx Health Company Detail
11.8.2 MDx Health Business Overview
11.8.3 MDx Health Prostate Cancer Diagnostics Solution Introduction
11.8.4 MDx Health Revenue in Prostate Cancer Diagnostics Solution Business (2018-2023)
11.8.5 MDx Health Recent Development
11.9 DiaSorin
11.9.1 DiaSorin Company Detail
11.9.2 DiaSorin Business Overview
11.9.3 DiaSorin Prostate Cancer Diagnostics Solution Introduction
11.9.4 DiaSorin Revenue in Prostate Cancer Diagnostics Solution Business (2018-2023)
11.9.5 DiaSorin Recent Development
11.10 Myriad Genetics
11.10.1 Myriad Genetics Company Detail
11.10.2 Myriad Genetics Business Overview
11.10.3 Myriad Genetics Prostate Cancer Diagnostics Solution Introduction
11.10.4 Myriad Genetics Revenue in Prostate Cancer Diagnostics Solution Business (2018-2023)
11.10.5 Myriad Genetics Recent Development
11.11 Ambry Genetics
11.11.1 Ambry Genetics Company Detail
11.11.2 Ambry Genetics Business Overview
11.11.3 Ambry Genetics Prostate Cancer Diagnostics Solution Introduction
11.11.4 Ambry Genetics Revenue in Prostate Cancer Diagnostics Solution Business (2018-2023)
11.11.5 Ambry Genetics Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
LIST OF TABLES
Table 1. Global Prostate Cancer Diagnostics Solution Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Tumor Biomarker Tests
Table 3. Key Players of Imaging
Table 4. Key Players of Biopsy
Table 5. Key Players of Other
Table 6. Global Prostate Cancer Diagnostics Solution Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Prostate Cancer Diagnostics Solution Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Prostate Cancer Diagnostics Solution Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Prostate Cancer Diagnostics Solution Market Share by Region (2018-2023)
Table 10. Global Prostate Cancer Diagnostics Solution Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Prostate Cancer Diagnostics Solution Market Share by Region (2024-2029)
Table 12. Prostate Cancer Diagnostics Solution Market Trends
Table 13. Prostate Cancer Diagnostics Solution Market Drivers
Table 14. Prostate Cancer Diagnostics Solution Market Challenges
Table 15. Prostate Cancer Diagnostics Solution Market Restraints
Table 16. Global Prostate Cancer Diagnostics Solution Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Prostate Cancer Diagnostics Solution Market Share by Players (2018-2023)
Table 18. Global Top Prostate Cancer Diagnostics Solution Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Diagnostics Solution as of 2022)
Table 19. Ranking of Global Top Prostate Cancer Diagnostics Solution Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Prostate Cancer Diagnostics Solution Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Prostate Cancer Diagnostics Solution Product Solution and Service
Table 23. Date of Enter into Prostate Cancer Diagnostics Solution Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Prostate Cancer Diagnostics Solution Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Prostate Cancer Diagnostics Solution Revenue Market Share by Type (2018-2023)
Table 27. Global Prostate Cancer Diagnostics Solution Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Prostate Cancer Diagnostics Solution Revenue Market Share by Type (2024-2029)
Table 29. Global Prostate Cancer Diagnostics Solution Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Prostate Cancer Diagnostics Solution Revenue Market Share by Application (2018-2023)
Table 31. Global Prostate Cancer Diagnostics Solution Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Prostate Cancer Diagnostics Solution Revenue Market Share by Application (2024-2029)
Table 33. North America Prostate Cancer Diagnostics Solution Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 34. North America Prostate Cancer Diagnostics Solution Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Prostate Cancer Diagnostics Solution Market Size by Country (2024-2029) & (US$ Million)
Table 36. Europe Prostate Cancer Diagnostics Solution Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. Europe Prostate Cancer Diagnostics Solution Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Prostate Cancer Diagnostics Solution Market Size by Country (2024-2029) & (US$ Million)
Table 39. Asia-Pacific Prostate Cancer Diagnostics Solution Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 40. Asia-Pacific Prostate Cancer Diagnostics Solution Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Prostate Cancer Diagnostics Solution Market Size by Region (2024-2029) & (US$ Million)
Table 42. Latin America Prostate Cancer Diagnostics Solution Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Latin America Prostate Cancer Diagnostics Solution Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Prostate Cancer Diagnostics Solution Market Size by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Prostate Cancer Diagnostics Solution Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Middle East & Africa Prostate Cancer Diagnostics Solution Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Prostate Cancer Diagnostics Solution Market Size by Country (2024-2029) & (US$ Million)
Table 48. OPKO Company Detail
Table 49. OPKO Business Overview
Table 50. OPKO Prostate Cancer Diagnostics Solution Product
Table 51. OPKO Revenue in Prostate Cancer Diagnostics Solution Business (2018-2023) & (US$ Million)
Table 52. OPKO Recent Development
Table 53. Genomic Health Company Detail
Table 54. Genomic Health Business Overview
Table 55. Genomic Health Prostate Cancer Diagnostics Solution Product
Table 56. Genomic Health Revenue in Prostate Cancer Diagnostics Solution Business (2018-2023) & (US$ Million)
Table 57. Genomic Health Recent Development
Table 58. Abbott Company Detail
Table 59. Abbott Business Overview
Table 60. Abbott Prostate Cancer Diagnostics Solution Product
Table 61. Abbott Revenue in Prostate Cancer Diagnostics Solution Business (2018-2023) & (US$ Million)
Table 62. Abbott Recent Development
Table 63. Beckman Coulter Company Detail
Table 64. Beckman Coulter Business Overview
Table 65. Beckman Coulter Prostate Cancer Diagnostics Solution Product
Table 66. Beckman Coulter Revenue in Prostate Cancer Diagnostics Solution Business (2018-2023) & (US$ Million)
Table 67. Beckman Coulter Recent Development
Table 68. Siemens Healthcare Company Detail
Table 69. Siemens Healthcare Business Overview
Table 70. Siemens Healthcare Prostate Cancer Diagnostics Solution Product
Table 71. Siemens Healthcare Revenue in Prostate Cancer Diagnostics Solution Business (2018-2023) & (US$ Million)
Table 72. Siemens Healthcare Recent Development
Table 73. bioMeriux Company Detail
Table 74. bioMeriux Business Overview
Table 75. bioMeriux Prostate Cancer Diagnostics Solution Product
Table 76. bioMeriux Revenue in Prostate Cancer Diagnostics Solution Business (2018-2023) & (US$ Million)
Table 77. bioMeriux Recent Development
Table 78. Roche Company Detail
Table 79. Roche Business Overview
Table 80. Roche Prostate Cancer Diagnostics Solution Product
Table 81. Roche Revenue in Prostate Cancer Diagnostics Solution Business (2018-2023) & (US$ Million)
Table 82. Roche Recent Development
Table 83. MDx Health Company Detail
Table 84. MDx Health Business Overview
Table 85. MDx Health Prostate Cancer Diagnostics Solution Product
Table 86. MDx Health Revenue in Prostate Cancer Diagnostics Solution Business (2018-2023) & (US$ Million)
Table 87. MDx Health Recent Development
Table 88. DiaSorin Company Detail
Table 89. DiaSorin Business Overview
Table 90. DiaSorin Prostate Cancer Diagnostics Solution Product
Table 91. DiaSorin Revenue in Prostate Cancer Diagnostics Solution Business (2018-2023) & (US$ Million)
Table 92. DiaSorin Recent Development
Table 93. Myriad Genetics Company Detail
Table 94. Myriad Genetics Business Overview
Table 95. Myriad Genetics Prostate Cancer Diagnostics Solution Product
Table 96. Myriad Genetics Revenue in Prostate Cancer Diagnostics Solution Business (2018-2023) & (US$ Million)
Table 97. Myriad Genetics Recent Development
Table 98. Ambry Genetics Company Detail
Table 99. Ambry Genetics Business Overview
Table 100. Ambry Genetics Prostate Cancer Diagnostics Solution Product
Table 101. Ambry Genetics Revenue in Prostate Cancer Diagnostics Solution Business (2018-2023) & (US$ Million)
Table 102. Ambry Genetics Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
Table 1. Global Prostate Cancer Diagnostics Solution Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Tumor Biomarker Tests
Table 3. Key Players of Imaging
Table 4. Key Players of Biopsy
Table 5. Key Players of Other
Table 6. Global Prostate Cancer Diagnostics Solution Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Prostate Cancer Diagnostics Solution Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Prostate Cancer Diagnostics Solution Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Prostate Cancer Diagnostics Solution Market Share by Region (2018-2023)
Table 10. Global Prostate Cancer Diagnostics Solution Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Prostate Cancer Diagnostics Solution Market Share by Region (2024-2029)
Table 12. Prostate Cancer Diagnostics Solution Market Trends
Table 13. Prostate Cancer Diagnostics Solution Market Drivers
Table 14. Prostate Cancer Diagnostics Solution Market Challenges
Table 15. Prostate Cancer Diagnostics Solution Market Restraints
Table 16. Global Prostate Cancer Diagnostics Solution Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Prostate Cancer Diagnostics Solution Market Share by Players (2018-2023)
Table 18. Global Top Prostate Cancer Diagnostics Solution Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Diagnostics Solution as of 2022)
Table 19. Ranking of Global Top Prostate Cancer Diagnostics Solution Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Prostate Cancer Diagnostics Solution Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Prostate Cancer Diagnostics Solution Product Solution and Service
Table 23. Date of Enter into Prostate Cancer Diagnostics Solution Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Prostate Cancer Diagnostics Solution Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Prostate Cancer Diagnostics Solution Revenue Market Share by Type (2018-2023)
Table 27. Global Prostate Cancer Diagnostics Solution Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Prostate Cancer Diagnostics Solution Revenue Market Share by Type (2024-2029)
Table 29. Global Prostate Cancer Diagnostics Solution Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Prostate Cancer Diagnostics Solution Revenue Market Share by Application (2018-2023)
Table 31. Global Prostate Cancer Diagnostics Solution Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Prostate Cancer Diagnostics Solution Revenue Market Share by Application (2024-2029)
Table 33. North America Prostate Cancer Diagnostics Solution Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 34. North America Prostate Cancer Diagnostics Solution Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Prostate Cancer Diagnostics Solution Market Size by Country (2024-2029) & (US$ Million)
Table 36. Europe Prostate Cancer Diagnostics Solution Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. Europe Prostate Cancer Diagnostics Solution Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Prostate Cancer Diagnostics Solution Market Size by Country (2024-2029) & (US$ Million)
Table 39. Asia-Pacific Prostate Cancer Diagnostics Solution Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 40. Asia-Pacific Prostate Cancer Diagnostics Solution Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Prostate Cancer Diagnostics Solution Market Size by Region (2024-2029) & (US$ Million)
Table 42. Latin America Prostate Cancer Diagnostics Solution Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Latin America Prostate Cancer Diagnostics Solution Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Prostate Cancer Diagnostics Solution Market Size by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Prostate Cancer Diagnostics Solution Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Middle East & Africa Prostate Cancer Diagnostics Solution Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Prostate Cancer Diagnostics Solution Market Size by Country (2024-2029) & (US$ Million)
Table 48. OPKO Company Detail
Table 49. OPKO Business Overview
Table 50. OPKO Prostate Cancer Diagnostics Solution Product
Table 51. OPKO Revenue in Prostate Cancer Diagnostics Solution Business (2018-2023) & (US$ Million)
Table 52. OPKO Recent Development
Table 53. Genomic Health Company Detail
Table 54. Genomic Health Business Overview
Table 55. Genomic Health Prostate Cancer Diagnostics Solution Product
Table 56. Genomic Health Revenue in Prostate Cancer Diagnostics Solution Business (2018-2023) & (US$ Million)
Table 57. Genomic Health Recent Development
Table 58. Abbott Company Detail
Table 59. Abbott Business Overview
Table 60. Abbott Prostate Cancer Diagnostics Solution Product
Table 61. Abbott Revenue in Prostate Cancer Diagnostics Solution Business (2018-2023) & (US$ Million)
Table 62. Abbott Recent Development
Table 63. Beckman Coulter Company Detail
Table 64. Beckman Coulter Business Overview
Table 65. Beckman Coulter Prostate Cancer Diagnostics Solution Product
Table 66. Beckman Coulter Revenue in Prostate Cancer Diagnostics Solution Business (2018-2023) & (US$ Million)
Table 67. Beckman Coulter Recent Development
Table 68. Siemens Healthcare Company Detail
Table 69. Siemens Healthcare Business Overview
Table 70. Siemens Healthcare Prostate Cancer Diagnostics Solution Product
Table 71. Siemens Healthcare Revenue in Prostate Cancer Diagnostics Solution Business (2018-2023) & (US$ Million)
Table 72. Siemens Healthcare Recent Development
Table 73. bioMeriux Company Detail
Table 74. bioMeriux Business Overview
Table 75. bioMeriux Prostate Cancer Diagnostics Solution Product
Table 76. bioMeriux Revenue in Prostate Cancer Diagnostics Solution Business (2018-2023) & (US$ Million)
Table 77. bioMeriux Recent Development
Table 78. Roche Company Detail
Table 79. Roche Business Overview
Table 80. Roche Prostate Cancer Diagnostics Solution Product
Table 81. Roche Revenue in Prostate Cancer Diagnostics Solution Business (2018-2023) & (US$ Million)
Table 82. Roche Recent Development
Table 83. MDx Health Company Detail
Table 84. MDx Health Business Overview
Table 85. MDx Health Prostate Cancer Diagnostics Solution Product
Table 86. MDx Health Revenue in Prostate Cancer Diagnostics Solution Business (2018-2023) & (US$ Million)
Table 87. MDx Health Recent Development
Table 88. DiaSorin Company Detail
Table 89. DiaSorin Business Overview
Table 90. DiaSorin Prostate Cancer Diagnostics Solution Product
Table 91. DiaSorin Revenue in Prostate Cancer Diagnostics Solution Business (2018-2023) & (US$ Million)
Table 92. DiaSorin Recent Development
Table 93. Myriad Genetics Company Detail
Table 94. Myriad Genetics Business Overview
Table 95. Myriad Genetics Prostate Cancer Diagnostics Solution Product
Table 96. Myriad Genetics Revenue in Prostate Cancer Diagnostics Solution Business (2018-2023) & (US$ Million)
Table 97. Myriad Genetics Recent Development
Table 98. Ambry Genetics Company Detail
Table 99. Ambry Genetics Business Overview
Table 100. Ambry Genetics Prostate Cancer Diagnostics Solution Product
Table 101. Ambry Genetics Revenue in Prostate Cancer Diagnostics Solution Business (2018-2023) & (US$ Million)
Table 102. Ambry Genetics Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Prostate Cancer Diagnostics Solution Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Prostate Cancer Diagnostics Solution Market Share by Type: 2022 VS 2029
Figure 3. Tumor Biomarker Tests Features
Figure 4. Imaging Features
Figure 5. Biopsy Features
Figure 6. Other Features
Figure 7. Global Prostate Cancer Diagnostics Solution Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Prostate Cancer Diagnostics Solution Market Share by Application: 2022 VS 2029
Figure 9. Age Below 55 Case Studies
Figure 10. Age 55-75 Case Studies
Figure 11. Age Above 75 Case Studies
Figure 12. Prostate Cancer Diagnostics Solution Report Years Considered
Figure 13. Global Prostate Cancer Diagnostics Solution Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Prostate Cancer Diagnostics Solution Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Prostate Cancer Diagnostics Solution Market Share by Region: 2022 VS 2029
Figure 16. Global Prostate Cancer Diagnostics Solution Market Share by Players in 2022
Figure 17. Global Top Prostate Cancer Diagnostics Solution Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Diagnostics Solution as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Prostate Cancer Diagnostics Solution Revenue in 2022
Figure 19. North America Prostate Cancer Diagnostics Solution Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Prostate Cancer Diagnostics Solution Market Share by Country (2018-2029)
Figure 21. United States Prostate Cancer Diagnostics Solution Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Prostate Cancer Diagnostics Solution Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Prostate Cancer Diagnostics Solution Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Prostate Cancer Diagnostics Solution Market Share by Country (2018-2029)
Figure 25. Germany Prostate Cancer Diagnostics Solution Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. France Prostate Cancer Diagnostics Solution Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. U.K. Prostate Cancer Diagnostics Solution Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Italy Prostate Cancer Diagnostics Solution Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Russia Prostate Cancer Diagnostics Solution Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Nordic Countries Prostate Cancer Diagnostics Solution Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Prostate Cancer Diagnostics Solution Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Prostate Cancer Diagnostics Solution Market Share by Region (2018-2029)
Figure 33. China Prostate Cancer Diagnostics Solution Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Japan Prostate Cancer Diagnostics Solution Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. South Korea Prostate Cancer Diagnostics Solution Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Southeast Asia Prostate Cancer Diagnostics Solution Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. India Prostate Cancer Diagnostics Solution Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Australia Prostate Cancer Diagnostics Solution Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Prostate Cancer Diagnostics Solution Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Prostate Cancer Diagnostics Solution Market Share by Country (2018-2029)
Figure 41. Mexico Prostate Cancer Diagnostics Solution Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Brazil Prostate Cancer Diagnostics Solution Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Prostate Cancer Diagnostics Solution Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Prostate Cancer Diagnostics Solution Market Share by Country (2018-2029)
Figure 45. Turkey Prostate Cancer Diagnostics Solution Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Saudi Arabia Prostate Cancer Diagnostics Solution Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. OPKO Revenue Growth Rate in Prostate Cancer Diagnostics Solution Business (2018-2023)
Figure 48. Genomic Health Revenue Growth Rate in Prostate Cancer Diagnostics Solution Business (2018-2023)
Figure 49. Abbott Revenue Growth Rate in Prostate Cancer Diagnostics Solution Business (2018-2023)
Figure 50. Beckman Coulter Revenue Growth Rate in Prostate Cancer Diagnostics Solution Business (2018-2023)
Figure 51. Siemens Healthcare Revenue Growth Rate in Prostate Cancer Diagnostics Solution Business (2018-2023)
Figure 52. bioMeriux Revenue Growth Rate in Prostate Cancer Diagnostics Solution Business (2018-2023)
Figure 53. Roche Revenue Growth Rate in Prostate Cancer Diagnostics Solution Business (2018-2023)
Figure 54. MDx Health Revenue Growth Rate in Prostate Cancer Diagnostics Solution Business (2018-2023)
Figure 55. DiaSorin Revenue Growth Rate in Prostate Cancer Diagnostics Solution Business (2018-2023)
Figure 56. Myriad Genetics Revenue Growth Rate in Prostate Cancer Diagnostics Solution Business (2018-2023)
Figure 57. Ambry Genetics Revenue Growth Rate in Prostate Cancer Diagnostics Solution Business (2018-2023)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Figure 1. Global Prostate Cancer Diagnostics Solution Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Prostate Cancer Diagnostics Solution Market Share by Type: 2022 VS 2029
Figure 3. Tumor Biomarker Tests Features
Figure 4. Imaging Features
Figure 5. Biopsy Features
Figure 6. Other Features
Figure 7. Global Prostate Cancer Diagnostics Solution Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Prostate Cancer Diagnostics Solution Market Share by Application: 2022 VS 2029
Figure 9. Age Below 55 Case Studies
Figure 10. Age 55-75 Case Studies
Figure 11. Age Above 75 Case Studies
Figure 12. Prostate Cancer Diagnostics Solution Report Years Considered
Figure 13. Global Prostate Cancer Diagnostics Solution Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Prostate Cancer Diagnostics Solution Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Prostate Cancer Diagnostics Solution Market Share by Region: 2022 VS 2029
Figure 16. Global Prostate Cancer Diagnostics Solution Market Share by Players in 2022
Figure 17. Global Top Prostate Cancer Diagnostics Solution Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Diagnostics Solution as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Prostate Cancer Diagnostics Solution Revenue in 2022
Figure 19. North America Prostate Cancer Diagnostics Solution Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Prostate Cancer Diagnostics Solution Market Share by Country (2018-2029)
Figure 21. United States Prostate Cancer Diagnostics Solution Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Prostate Cancer Diagnostics Solution Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Prostate Cancer Diagnostics Solution Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Prostate Cancer Diagnostics Solution Market Share by Country (2018-2029)
Figure 25. Germany Prostate Cancer Diagnostics Solution Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. France Prostate Cancer Diagnostics Solution Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. U.K. Prostate Cancer Diagnostics Solution Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Italy Prostate Cancer Diagnostics Solution Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Russia Prostate Cancer Diagnostics Solution Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Nordic Countries Prostate Cancer Diagnostics Solution Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Prostate Cancer Diagnostics Solution Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Prostate Cancer Diagnostics Solution Market Share by Region (2018-2029)
Figure 33. China Prostate Cancer Diagnostics Solution Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Japan Prostate Cancer Diagnostics Solution Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. South Korea Prostate Cancer Diagnostics Solution Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Southeast Asia Prostate Cancer Diagnostics Solution Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. India Prostate Cancer Diagnostics Solution Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Australia Prostate Cancer Diagnostics Solution Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Prostate Cancer Diagnostics Solution Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Prostate Cancer Diagnostics Solution Market Share by Country (2018-2029)
Figure 41. Mexico Prostate Cancer Diagnostics Solution Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Brazil Prostate Cancer Diagnostics Solution Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Prostate Cancer Diagnostics Solution Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Prostate Cancer Diagnostics Solution Market Share by Country (2018-2029)
Figure 45. Turkey Prostate Cancer Diagnostics Solution Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Saudi Arabia Prostate Cancer Diagnostics Solution Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. OPKO Revenue Growth Rate in Prostate Cancer Diagnostics Solution Business (2018-2023)
Figure 48. Genomic Health Revenue Growth Rate in Prostate Cancer Diagnostics Solution Business (2018-2023)
Figure 49. Abbott Revenue Growth Rate in Prostate Cancer Diagnostics Solution Business (2018-2023)
Figure 50. Beckman Coulter Revenue Growth Rate in Prostate Cancer Diagnostics Solution Business (2018-2023)
Figure 51. Siemens Healthcare Revenue Growth Rate in Prostate Cancer Diagnostics Solution Business (2018-2023)
Figure 52. bioMeriux Revenue Growth Rate in Prostate Cancer Diagnostics Solution Business (2018-2023)
Figure 53. Roche Revenue Growth Rate in Prostate Cancer Diagnostics Solution Business (2018-2023)
Figure 54. MDx Health Revenue Growth Rate in Prostate Cancer Diagnostics Solution Business (2018-2023)
Figure 55. DiaSorin Revenue Growth Rate in Prostate Cancer Diagnostics Solution Business (2018-2023)
Figure 56. Myriad Genetics Revenue Growth Rate in Prostate Cancer Diagnostics Solution Business (2018-2023)
Figure 57. Ambry Genetics Revenue Growth Rate in Prostate Cancer Diagnostics Solution Business (2018-2023)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
